Trademark: 88850346
Word
ZILBRYSQ
Status Date
Monday, October 23, 2023
Filing Date
Friday, March 27, 2020
Published for Opposition
Tuesday, July 28, 2020
Abandoned Date
Monday, October 23, 2023
5 Pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory disorder, a wound, a burn, an autoimmune disorder, a pulmonary disorder, a cardiovascular disorder, a neurological disorder, a kidney-related disorder, a diabetes-related disorder, an ocular disorder, and a pregnancy-related disorder; Pharmaceutical preparations, for human use, for the prevention and treatment of disorders of metabolism, the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Pharmaceutical preparations for the treatment of fibrotic and inflammatory disorders; Pharmaceutical preparations for use in dermatology, nephrology, hepatology, rheumatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations as anti-viral, anti-bacterial, or anti-fungal agents
10 Syringes for injections; Syringes for medical purposes; Syringes for medical purposes sold empty which may be filled with pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory indication, a wound, a burn, an autoimmune indication, a pulmonary indication, a cardiovascular indication, a neurological indication, a kidney-related indication, a diabetes-related indication, an ocular indication, and a pregnancy-related indication
The wording ZILBRYSQ has no meaning in a foreign language.
Mar 31, 2020
New Application Entered
Apr 1, 2020
New Application Office Supplied Data Entered
Jun 18, 2020
Assigned To Examiner
Jun 18, 2020
Examiners Amendment -Written
Jun 18, 2020
Examiners Amendment E-Mailed
Jun 18, 2020
Notification Of Examiners Amendment E-Mailed
Jun 18, 2020
Examiner's Amendment Entered
Jul 8, 2020
Notification Of Notice Of Publication E-Mailed
Jun 18, 2020
Approved For Pub - Principal Register
Jun 22, 2020
Assigned To Lie
Jul 28, 2020
Published For Opposition
Jul 28, 2020
Official Gazette Publication Confirmation E-Mailed
Sep 1, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 1, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 1, 2020
Teas Change Of Correspondence Received
Sep 22, 2020
Noa E-Mailed - Sou Required From Applicant
Feb 22, 2021
Sou Teas Extension Received
Feb 22, 2021
Sou Extension 1 Filed
Feb 22, 2021
Sou Extension 1 Granted
Feb 24, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 26, 2021
Sou Extension 2 Filed
Aug 26, 2021
Sou Teas Extension Received
Aug 26, 2021
Sou Extension 2 Granted
Oct 25, 2021
Teas Withdrawal Of Attorney Received-Firm Retains
Aug 28, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 25, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 25, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 25, 2021
Teas Change Of Correspondence Received
Dec 13, 2021
Teas Withdrawal Of Attorney Received-Firm Retains
Dec 13, 2021
Teas Change Of Owner Address Received
Dec 13, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 13, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 13, 2021
Teas Change Of Correspondence Received
Dec 13, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 4, 2022
Sou Teas Extension Received
Mar 4, 2022
Sou Extension 3 Filed
Mar 4, 2022
Sou Extension 3 Granted
Aug 31, 2022
Sou Extension 4 Filed
Mar 8, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 31, 2022
Sou Teas Extension Received
Aug 31, 2022
Sou Extension 4 Granted
Sep 2, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 21, 2023
Sou Extension 5 Granted
Mar 8, 2023
Sou Teas Extension Received
Mar 8, 2023
Sou Extension 5 Filed
Mar 21, 2023
Case Assigned To Intent To Use Paralegal
Mar 22, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 23, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 23, 2023
Abandonment - No Use Statement Filed
Trademark Alertz updated from USPTO on 2030-01-24
